Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. HeraMED Limited
  6. News
  7. Summary
    HMD   AU0000028367

HERAMED LIMITED

(HMD)
SummaryChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

HeraMED Limited Announces Signed an Agreement with Joondalup Health Campus

04/21/2021 | 07:24pm EDT

HeraMED Limited announced it has signed an agreement with Joondalup Health Campus (JHC), which incorporates a paid pilot of its HeraCARE solution involving 100 expectant mothers as the initial phase of an anticipated commercial roll-out for the use of HeraMED's technology as a standard service, to be offered to all pregnant mothers under JHC's care. On 8 October 2020, HeraMED announced outstanding results from a clinical study undertaken by JHC that delivered clinical and functional validation of the HeraBEAT device. The accuracy of the HeraBEAT device was found to be excellent when compared to the industry gold standard CTG (Phillips Avalon) machine. The Foetal Heart Rate (FHR) was detected on 100% of occasions by clinicians and importantly, the FHR was detected on 100% of occasions by the expectant mothers when using the device without assistance. Today's agreement represents an important next stage of the collaboration in which JHC is undertaking to incorporate the HeraCARE platform to introduce an innovative model for remote monitoring and care management for pregnant women, allowing for the HeraBEAT device and foetal heart rate data to be used in telehealth consultations.


ę S&P Capital IQ 2021
All news about HERAMED LIMITED
09/12HeraMED Limited Provides Positive Interim Results US Paid Pilot & 2nd Site Confirmed
CI
08/27HeraMED Limited Reports Earnings Results for the Half Year Ended June 30, 2021
CI
08/13HERAMED : Begins Pilot Program for Maternal Care Platform
MT
07/18HERAMED : Obstetrix Medical Signs Deal for Integration of Maternity Care Platform HeraCARE..
MT
07/18HeraMED Limited Announces Change of Registered Office
CI
07/18HeraMED Limited Announces Pilot Agreement with Obstetrix Medical Group
CI
05/13HERAMED : Enters Pilot Deal With US Clinical Services Provider
MT
05/12HeraMED Limited Announces Pilot Agreement with Obstetrix Medical Group
CI
04/22HERAMED : Signs Deal with Joondalup Health Campus for HeraCARE Platform; Shares Gain 4%
MT
04/21HeraMED Limited Announces Signed an Agreement with Joondalup Health Campus
CI
More news
Financials (USD)
Sales 2020 0,04 M - -
Net income 2020 -3,36 M - -
Net cash 2020 1,75 M - -
P/E ratio 2020 -4,12x
Yield 2020 -
Capitalization 27,0 M 27,0 M -
EV / Sales 2019 67,0x
EV / Sales 2020 277x
Nbr of Employees -
Free-Float 61,5%
Chart HERAMED LIMITED
Duration : Period :
HeraMED Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HERAMED LIMITED
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Managers and Directors
David Groberman Chief Executive Officer, Director & MD
Sivan Sadan Chief Financial Officer
Ronald Peter Weinberger Non-Executive Chairman
Josef Tovbin Chief Medical Officer
Michael Nenner Chief Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
HERAMED LIMITED90.91%27
THERMO FISHER SCIENTIFIC30.58%239 899
DANAHER CORPORATION46.32%231 660
INTUITIVE SURGICAL, INC.27.53%124 147
SIEMENS HEALTHINEERS AG42.12%78 408
EDWARDS LIFESCIENCES CORPORATION32.65%74 843